Lucira Health is the recipient of the first-ever emergency use authorization (EUA) for an at-home prescription diagnostic test kit for detecting SARS-CoV-2, the virus that causes COVID-19.
The US Food and Drug Administration granted the EUA on 17 November for the firm’s